Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial
Publication

Publications

Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial

Title
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial
Type
Article in International Scientific Journal
Year
2012
Authors
Immink, JM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Putter, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Bartelink, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cardoso, JS
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Cardoso, MJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
van der Hulst Vijgen, MHV
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Noordijk, EM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Poortmans, PM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rodenhuis, CC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Struikmans, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: Annals of OncologyImported from Authenticus Search for Journal Publications
Vol. 23 No. 10
Pages: 2591-2598
ISSN: 0923-7534
Publisher: Elsevier
Indexing
Scientific classification
FOS: Medical and Health sciences > Clinical medicine
Other information
Authenticus ID: P-002-4ZA
Abstract (EN): In breast cancer treated with breast-conserving radiotherapy, the influence of the boost dose on cosmetic outcome after long-term follow-up is unknown. We included 348 patients participating in the EORTC 'boost versus no boost' mega trial with a minimum follow-up of 6 years. Digitalised pictures were analysed using specific software, enabling quantification of seven relative asymmetry features associated with different aspects of fibrosis. After 3 years, we noted a statistically significantly poorer outcome for the boost patients for six features compared with those of the no boost patients. Up to 9 years of follow-up, results continued to worsen in the same magnitude for the both patient groups. We noted the following determinants for poorer outcome: (i) boost treatment, (ii) larger excision volumes, (iii) younger age, (iv) tumours located in the central lower quadrants of the breast and (v) a boost dose administered with photons. A boost dose worsens the change in breast appearance in the first 3 years. Moreover, the development of fibrosis associated with whole-breast irradiation, as estimated with the relative asymmetry features, is an ongoing process until (at least) 9 years after irradiation.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Intratumoral heterogeneity in gastric cancer: a new challenge to face (2017)
Another Publication in an International Scientific Journal
Alsina, M; Gullo, I; Carneiro F
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) (2015)
Another Publication in an International Scientific Journal
Michiels, S; Negreiros, I; Offersen, BV; Llorca, FP; Pruneri, G; Roche, H; Russell, NS; Fernando Schmitt; Servent, V; Thuerlimann, B; Untch, M; van der Hage, JA; van Tienhoven, G; Wildiers, H; Yarnold, J; Bonnetain, F; Mathoulin Pelissier, S; Bellera, C; Dabakuyo Yonli, TS; Gourgou Bourgade, S...(mais 25 authors)
European Consensus Conference for external quality assessment in molecular pathology (2013)
Another Publication in an International Scientific Journal
van Krieken, JH; Siebers, AG; Normanno, N; Blackhall, F; Boone, E; Botti, G; Carneiro F; Celik, I; Ciardiello, F; Magrassi, F; Lanzara, A; Cree, IA; Deans, ZC; Dequeker, E; Edsjo, A; Groenen, PJTA; Kamarainen, O; Kreipe, HH; van Krieken, JH; Ligtenberg, MJL...(mais 16 authors)
Role of imatinib in progesterone-dependent breast cancer cells (2007)
Other Publications
da roche, as; azevedo, i; soares, r
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation (2013)
Article in International Scientific Journal
Ribeiro, C; Campelos, S; Moura, CS; Machado JC; Justino, A; Parente, B

See all (23)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-23 at 11:23:14 | Privacy Policy | Personal Data Protection Policy | Whistleblowing